HSDT.NASDAQHelius Medical Technologies, INC

SCHEDULE: L1 Capital Discloses 1.01% Stake in Helius Medical

Sentiment:

Beneficial Ownership Report

📋All filings for Helius Medical Technologies, INC
🔒Login to Follow

L1 Capital Global Opportunities Master Fund, Ltd. has filed an amended Schedule 13G, disclosing a 1.01% beneficial ownership stake in Helius Medical Technologies, Inc.

Capital raiseThe filing references shares and underlying warrants purchased on June 6, 2025.It refers to an "offering" and a "Prospectus filed under Rule 424(b)(4) with the Securities and Exchange Commission on June 6, 2025."The calculation of percentage ownership is based on shares outstanding "after the offering."

Summary

  • L1 Capital Global Opportunities Master Fund, Ltd. reported beneficial ownership of 640 shares of Helius Medical Technologies, Inc. common stock.
  • This ownership represents 1.01% of the company's common stock outstanding.
  • The reported shares consist of 203 shares of common stock and 437 shares underlying warrants.
  • This filing is an Amendment No. 1 to a Schedule 13G previously filed on June 13, 2025.
  • The percentage ownership is calculated based on 63,102 post-split common shares outstanding as of June 6, 2025, following a 1-for-50 reverse stock split effective June 30, 2025.

Sentiment

Score: 5

Explanation: This is a neutral, factual disclosure of beneficial ownership, not indicative of positive or negative company performance.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: Provides transparency regarding institutional ownership, potentially signaling institutional interest in the company.

Key Dates

DateDescription
2025-06-06Shares and underlying warrants purchased; date of prospectus filing and shares outstanding calculation.
2025-06-13Original Schedule 13G filing date.
2025-06-30Effective date of Helius Medical Technologies' 1-for-50 reverse stock split.
2025-08-14Date of event requiring this Schedule 13G Amendment No. 1 filing.

Keywords

Helius Medical Technologies, L1 Capital, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, Medical Technology, Investment Fund, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.